Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:38
Elutia Total Assets (Quarterly) : 48.19M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 48.19M |
| June 30, 2026 | 43.65M |
| March 31, 2026 | 55.21M |
| December 31, 2025 | 62.35M |
| September 30, 2025 | 29.41M |
| June 30, 2025 | 33.85M |
| March 31, 2025 | 39.30M |
| December 31, 2024 | 36.13M |
| September 30, 2024 | 48.41M |
| June 30, 2024 | 41.90M |
| March 31, 2024 | 35.36M |
| December 31, 2023 | 43.43M |
| September 30, 2023 | 54.58M |
| Date | Value |
|---|---|
| June 30, 2023 | 52.33M |
| March 31, 2023 | 60.63M |
| December 31, 2022 | 68.84M |
| September 30, 2022 | 61.02M |
| June 30, 2022 | 52.85M |
| March 31, 2022 | 59.93M |
| December 31, 2021 | 67.17M |
| September 30, 2021 | 59.90M |
| June 30, 2021 | 69.70M |
| March 31, 2021 | 74.21M |
| December 31, 2020 | 82.81M |
| September 30, 2020 | 46.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 245.55M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 189.60M |
| BioCryst Pharmaceuticals, Inc. | 591.07M |
| Imunon, Inc. | 12.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.87M |
| Shareholders Equity (Quarterly) | 15.32M |
| Debt to Equity Ratio | 1.046 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | 12.15% |